Cite
HARVARD Citation
Gomberg, S. et al. (n.d.). Patients with N3 non-small cell lung cancer (NSCLC) treated with radical chemoradiation can expect similar survival to patients with N2 disease. Lung cancer. pp. S79-S80. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gomberg, S. et al. (n.d.). Patients with N3 non-small cell lung cancer (NSCLC) treated with radical chemoradiation can expect similar survival to patients with N2 disease. Lung cancer. pp. S79-S80. [Online].